The ischemic penumbra represents a specifi c tissue region surrounding the ischemic core that has been identifi ed from more than 48 h after stroke in patients, and that has intermediate perfusion, where cells depolarize intermittently [1] . Without treatment, the penumbra often progresses to infarction owing to the effects of ongoing excitotoxicity, spreading depolarization and postischemic infl ammation. Maintenance of perfusion pressure in this region and hence survival of neurons within this electrophysiologically dynamic area of tissue is critical for the minimization of long-term damage. Because of these factors, the penumbra clearly has a limited life span and appears to undergo irreversible damage within a few hours unless reperfusion is initiated and/or neuroprotective therapy administered.
Sharp et al. [2] proposed the existence of multiple 'molecular penumbras' that represent zones within which differential patterns of gene expression are determined on the basis of differential perfusion levels. A number of studies have examined gene regulation after ischemic stroke in animal models and in humans, using cDNAprinted microarrays [3] [4] [5] , and have demonstrated deregulation of numerous novel genes. Some ischemia-hypoxia response genes were upregulated and some were downregulated; these consisted of immediate early genes, heat shock proteins, antioxidative enzymes, trophic fac- provide new insights into the aggregate genetic control of stroke injury, and the interrelationship of important cellular events within the damaged region.
The molecular signals for poststroke angiogenesis begin within hours of initial cerebral ischemia, with sequential increases in message for initially destabilizing combinations of vascular growth factors and growth factor receptors, followed by growth factor combinations that promote endothelial cell division and stabilization. The overlap in molecular signaling between poststroke angiogenesis, neurogenesis and axonal sprouting suggests a continuum of vascular and neural reorganization in the tissue adjacent to stroke. The changes of protein synthesis are reversible in the ischemia-resistant cortex in animals, but persist in the vulnerable regions [8] . In the vulnerable regions, apoptotic programs are induced, closely in parallel with the manifestation of delayed cell death. Thus, the recovery of protein synthesis may be a major factor infl uencing tissue survival after stroke. In addition, components of an adult neuronal growth program have been identifi ed in the peripheral nervous system during axonal regeneration, with an overlap to axonal sprouting after stroke. The gene expression profi le of the aged brain suggests an altered central nervous system environment that may exacerbate initial injury and impair neural reorganization after stroke.
In the recent past, progress in the ability to transfer proteins by protein transduction technology across the blood-brain barrier, as well as advances in neurological gene therapy, which has shown that brain defects in experimental disease models can be prevented and corrected, indicate that suffi cient information is now available to contemplate radical changes in treatment strategies in patients with stroke [9] . New methods of imaging provide a powerful tool to image the penumbra and should be used to monitor the therapeutic effects.
